C
Carasent ASA
OSE:CARA
Carasent ASA
OSE:CARA
Price:
18.55 NOK
-1.07%
Market Closed
Updated:
May 15, 2024
Section:
Relative Value
The Relative Value of one CARA stock under the Base Case scenario is 26.37 NOK. Compared to the current market price of 18.55 NOK, Carasent ASA is Undervalued by 30%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CARA
Relative Value
Base Case
26.37
NOK
Undervaluation 30%
C
Valuation Multiples
Multiples Across Competitors
CARA Competitors Multiples
Carasent ASA Competitors
Carasent ASA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NO |
C
|
Carasent ASA
OSE:CARA
|
1.3B NOK | 5.3 | -24 | 57.8 | -28 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
33.9B USD | 14.3 | 64.5 | 64.6 | 69.5 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12.2B AUD | 83.2 | 174.5 | 120 | 120 | |
| JP |
|
M3 Inc
TSE:2413
|
1.2T JPY | 4.9 | 24.8 | 13 | 14.6 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
4.6B USD | 7 | -293.8 | -127.1 | -116.1 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 9.5 | 32.2 | 21.2 | 22.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
46.9B SEK | 28.6 | 110.4 | -72.7 | -72.7 | |
| US |
|
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 11.7 | -324 | 264.4 | 4 233.4 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.7B USD | 3.6 | -419.2 | 36.5 | -93.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
